Redwood Pharma
1.465 SEK +7.72%1 investor is following this company
Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
REDW
Daily low / high price
1.36 / 2.76
SEK
Market cap
3.89M SEK
Turnover
1.89M SEK
Volume
1M
Financial calendar
Interim report
2024-08-29
Interim report
2024-11-13
Annual report
2025-02-12
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Bank of New York Mellon SA/NV, W8IMY | 4.4 % | 4.4 % |
Avanza Pension | 4.3 % | 4.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Redwood Pharma provides a new update regarding divestment of company assets
Redwood Pharma tillhandahåller en ny uppdatering angående avyttring av företagets tillgångar
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools